Potential of caveolae in the therapy of cardiovascular and neurological diseases.

about

The Pathophysiology of Moyamoya Disease: An Update Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities.Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease.Editorial: Membrane domains as new drug targets.

P2860

Q26769012-2ED6FF8A-6281-43B9-B2E6-79E63E6E9F90 Q38304820-5EFDAFF7-2048-4F48-A597-23F2E85C5F18 Q38412128-311A7419-E46A-4D85-9C3B-E50903D42C8C Q41513306-7A8B58CD-0DE4-40F7-9048-D12A16837987

P2860

Potential of caveolae in the therapy of cardiovascular and neurological diseases.

Item

http://www.wikidata.org/entity/Q42921318

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Potential of caveolae in the therapy of cardiovascular and neurological diseases.

@en

Potential of caveolae in the therapy of cardiovascular and neurological diseases.

@nl

type

Item

label

Potential of caveolae in the therapy of cardiovascular and neurological diseases.

@en

Potential of caveolae in the therapy of cardiovascular and neurological diseases.

@nl

prefLabel

Potential of caveolae in the therapy of cardiovascular and neurological diseases.

@en

Potential of caveolae in the therapy of cardiovascular and neurological diseases.

@nl

P1476

Potential of caveolae in the therapy of cardiovascular and neurological diseases.

@en

P2860

Internalization of caveolin-1 scaffolding domain facilitated by Antennapedia homeodomain attenuates PAF-induced increase in microvessel permeability

Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3

Cell surface expression of human ether-a-go-go-related gene (hERG) channels is regulated by caveolin-3 protein via the ubiquitin ligase Nedd4-2

Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome

Identification, sequence, and expression of caveolin-2 defines a caveolin gene family

D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells

HERG, a human inward rectifier in the voltage-gated potassium channel family

The regulation of the cardiac potassium channel (HERG) by caveolin-1

Caveolinopathies: from the biology of caveolin-3 to human diseases

LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model

P304

370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHYS.2014.00370

http://www.w3.org/2001/XMLSchema#string

P4011

a64dd554a2e60dd4cac06616611e6d0dc38249ab

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kjell Fuxe

Rafael Franco

DASIEL OSCAR BORROTO ESCUELA

Gemma Navarro

P577

2014-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267044344

http://www.w3.org/2001/XMLSchema#string

P698

25324780

http://www.w3.org/2001/XMLSchema#string

P932

4179688

http://www.w3.org/2001/XMLSchema#string

Potential of caveolae in the therapy of cardiovascular and neurological diseases.

about

P2860

P2860

Potential of caveolae in the therapy of cardiovascular and neurological diseases.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P4011

P407

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2860

P304

P31

P356

P4011

P407

P478

P50

P577

P5875

P698

P932